HROW
Harrow Health IncNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$1.32B
P/E Ratio
—
EPS
$-0.14
Beta
0.31
52W High
$54.85
52W Low
$21.12
50-Day MA
$42.01
200-Day MA
$40.67
Dividend Yield
—
Profit Margin
-1.89%
Forward P/E
62.89
PEG Ratio
—
About Harrow Health Inc
Harrow Health, Inc. is an ophthalmology-focused healthcare company. The company is headquartered in San Diego, California.
Fundamentals
| Revenue (TTM) | $272.30M |
| Gross Profit (TTM) | $204.37M |
| EBITDA | $48.82M |
| Operating Margin | 17.50% |
| Return on Equity | -8.47% |
| Return on Assets | 4.84% |
| Revenue/Share (TTM) | $7.41 |
| Book Value | $1.41 |
| Price-to-Book | 25.05 |
| Price-to-Sales (TTM) | 4.84 |
| EV/Revenue | 5.48 |
| EV/EBITDA | 35.14 |
| Quarterly Earnings Growth (YoY) | -10.30% |
| Quarterly Revenue Growth (YoY) | 33.30% |
| Shares Outstanding | $37.23M |
| Float | $27.35M |
| % Insiders | 16.14% |
| % Institutions | 60.64% |
Analyst Ratings
Consensus ($69.38 target)
8
BuyData last updated: 4/8/2026